Insights / Publications

White Paper: Rethinking Pharma Supply Chain Resilience in 2021

The LogiPharma 2021 Benchmark Report

Pills being manufactured

Sign up for the Controlant newsletter

Keep up with developments in pharma supply chain visibility. Sign up for Controlant Insights and receive our latest white paper.

Never before have pharma supply-chain leaders faced more complex, turbulent conditions than during the COVID-19 pandemic. For many, it has been a crash course in crisis management and a stark warning of the need to build resilience against future shocks. Download the report and learn how more than 100 Directors of Supply Chain Management and similar roles from pharmaceutical companies across the world are increasing visibility across their global supply chain through technology.

Covered topics include:

  • How COVID-19 has affected business operations and global pharmaceutical supply chain.
  • The current gaps which are likely to be the most problematic if not addressed before any future disruption and ways to mitigate them.
  • The benefits of measuring ROI provided by real-time temperature monitoring technology.
  • Ways real-time visibility solutions support pharmaceutical supply chain strategies and prepare organizations for future disruption.

Read the free LogiPharma Benchmark Report 2021